{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T23:49:48Z","timestamp":1768866588221,"version":"3.49.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T00:00:00Z","timestamp":1302825600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0018924","type":"journal-article","created":{"date-parts":[[2011,4,16]],"date-time":"2011-04-16T03:07:22Z","timestamp":1302923242000},"page":"e18924","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Adverse Events Post Smallpox-Vaccination: Insights from Tail Scarification Infection in Mice with Vaccinia virus"],"prefix":"10.1371","volume":"6","author":[{"given":"Bruno E. F.","family":"Mota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Gallardo-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giliane","family":"Trindade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Shannon","family":"Keckler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Karem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darin","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leda Q.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1vio G.","family":"da Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo C. P.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udio A.","family":"Bonjardim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger K.","family":"Damon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erna G.","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,4,15]]},"reference":[{"key":"ref1","article-title":"Poxviridae: The viruses and their replication.","author":"B Moss","year":"2001"},{"key":"ref2","article-title":"Smallpox and its eradication.","author":"FHD Fenner","year":"1988"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1086\/374244","article-title":"Progressive vaccinia.","volume":"36","author":"M Bray","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.","volume":"11","author":"Y Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.2009.289","article-title":"Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8.","volume":"301","author":"T Saito","year":"2009","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.","volume":"100","author":"IM Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nm.2078","article-title":"Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity.","volume":"16","author":"L Liu","year":"2010","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.4049\/jimmunol.175.10.6829","article-title":"Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus.","volume":"175","author":"M Fang","year":"2005","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/375825","article-title":"Smallpox vaccination: a review, part II. Adverse events.","volume":"37","author":"VA Fulginiti","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1016\/j.vaccine.2007.09.023","article-title":"Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice.","volume":"25","author":"S Melamed","year":"2007","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2006.12.645","article-title":"Skin inflammation in RelB(-\/-) mice leads to defective immunity and impaired clearance of vaccinia virus.","volume":"119","author":"EJ Freyschmidt","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/jid.2008.191","article-title":"Overexpression of IL-1alpha in skin differentially modulates the immune response to scarification with vaccinia virus.","volume":"129","author":"T Tian","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1084\/jem.20082835","article-title":"Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum.","volume":"206","author":"Y Kawakami","year":"2009","journal-title":"J Exp Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.immuni.2006.02.006","article-title":"Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus.","volume":"24","author":"MD Howell","year":"2006","journal-title":"Immunity"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","article-title":"Cellular and humoral immunity against vaccinia virus infection of mice.","volume":"172","author":"R Xu","year":"2004","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1128\/JVI.00116-06","article-title":"Obligatory requirement for antibody in recovery from a primary poxvirus infection.","volume":"80","author":"G Chaudhri","year":"2006","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1099\/0022-1317-83-5-1059","article-title":"Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions.","volume":"83","author":"JC Ramirez","year":"2002","journal-title":"J Gen Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1086\/377275","article-title":"Role of antibody in recovery from severe vaccinia virus infection.","volume":"37","author":"M Worthington","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7861\/clinmedicine.3-3-255","article-title":"Anticipating smallpox as a bioterrorist weapon.","volume":"3","author":"PP Mortimer","year":"2003","journal-title":"Clin Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/QCO.0b013e3282f44c74","article-title":"Cowpox virus infection: an emerging health threat.","volume":"21","author":"RM Vorou","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/17460913.2.1.17","article-title":"Human monkeypox: an emerging zoonotic disease.","volume":"2","author":"S Parker","year":"2007","journal-title":"Future Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1073\/pnas.89.13.6070","article-title":"Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses.","volume":"89","author":"MK Spriggs","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1099\/vir.0.19120-0","article-title":"IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system.","volume":"84","author":"MM Gherardi","year":"2003","journal-title":"J Gen Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.4049\/jimmunol.179.6.3917","article-title":"IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17.","volume":"179","author":"S Kohyama","year":"2007","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1172\/JCI38506","article-title":"Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector\/memory CD4+ lymphocytes in humans.","volume":"120","author":"B Puissant-Lubrano","year":"2010","journal-title":"J Clin Invest"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/JVI.01927-06","article-title":"Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection.","volume":"81","author":"IG Sakala","year":"2007","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1128\/JVI.69.2.910-915.1995","article-title":"Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication.","volume":"69","author":"N Harris","year":"1995","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1126\/science.7690156","article-title":"Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase.","volume":"261","author":"G Karupiah","year":"1993","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/viro.1996.0141","article-title":"Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance.","volume":"217","author":"MS Rolph","year":"1996","journal-title":"Virology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/clin.1997.4475","article-title":"Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both.","volume":"86","author":"K Kohno","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1073\/pnas.081080298","article-title":"Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice.","volume":"98","author":"LP Perera","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","article-title":"RAG-1-deficient mice have no mature B and T lymphocytes.","volume":"68","author":"P Mombaerts","year":"1992","journal-title":"Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1128\/JVI.00115-06","article-title":"Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function.","volume":"80","author":"V Panchanathan","year":"2006","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.vaccine.2009.01.038","article-title":"Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response.","volume":"27","author":"S Lustig","year":"2009","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/eji.1830260943","article-title":"Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory.","volume":"26","author":"MA Brundler","year":"1996","journal-title":"Eur J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1099\/vir.0.81090-0","article-title":"Ectromelia virus: the causative agent of mousepox.","volume":"86","author":"DJ Esteban","year":"2005","journal-title":"J Gen Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/217370a0","article-title":"Absence of thymus in a mouse mutant.","volume":"217","author":"EM Pantelouris","year":"1968","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/AAC.48.6.2267-2273.2004","article-title":"Efficacy of cidofovir in a murine model of disseminated progressive vaccinia.","volume":"48","author":"J Neyts","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2008.04.018","article-title":"Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities.","volume":"28","author":"A Sette","year":"2008","journal-title":"Immunity"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e1000768","DOI":"10.1371\/journal.ppat.1000768","article-title":"Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response.","volume":"6","author":"RH Xu","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1086\/423851","article-title":"Clinical and immune responses after revaccination of israeli adults with the Lister strain of vaccinia virus.","volume":"190","author":"N Orr","year":"2004","journal-title":"J Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00705-010-0675-3","article-title":"Seroprevalence of orthopoxvirus in an Amazonian rural village, Acre, Brazil.","volume":"155","author":"BE Mota","year":"2010","journal-title":"Arch Virol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0018924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T09:35:00Z","timestamp":1592472900000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0018924"}},"subtitle":[],"editor":[{"given":"Dipshikha","family":"Chakravortty","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,4,15]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0018924","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,15]]}}}